| NCT Number | NCT06983028 |
| Lead Sponsor | Vera Therapeutics, Inc. |
| Conditions | pMN, IgAN, Nephrotic Syndrome, MCD, FSGS |
| Enrollment | 250 participants |
| Start Date | 2025-07-07 |
| Primary Completion | 2027-11 (estimated) |
| Study Completion | 2027-11 (estimated) |
| Updated on ClinicalTrials.gov | 2026-06-26 |